What is CSI
The Cancer Science Institute of Singapore (CSI Singapore) is a University Research Institute at the National University of Singapore. Officially launched on 15 October 2008. CSI Singapore aims to position Singapore as a global-leader in the field of Biomedical Sciences. It is dedicated to conducting a multifaceted and coordinated approach to cancer research, extending from basic cancer studies all the way to experimental therapeutics and in so doing improve cancer treatment.
The CSI Singapore is internationally recognized for its innovative research on the biology of cancers prevalent in Asia, and for taking new methods for cancer treatment from the laboratory to the clinic. Through its local and global partnerships, the CSI Singapore works with leading minds from multiple scientific and clinical disciplines both in academia and in industry.
Exceptionally strategic location
Our strategic location strongly facilitates collaborations and networking with external scientists. Based in the NUS campus, we are a short walk away from the Yong Loo School of Medicine and 1,200-bed National University Hospital.
We are also a short driving distance from other key research institutes such as IMCB and GIS at A*STAR and the Duke-NUS Graduate Medical School.
Diversity & Inclusion
We are home to an international pool of employees working towards a shared goal of advancing against cancer. We recognise the importance of diversity in fostering a creative environment of ideas, its value in enriching the research we do, and its ability to attract talent of all backgrounds.
CSI Director Shares His Thoughts on Building a Great and Inclusive Workplace
